retatrutide triple hormone receptor agonist weight loss ⭐️topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon agonist, in adults with obesity or “overweight” retatrutide liver safety Retatrutide: A

The pen is supplied for research use only

Ferroptosis and cell death mechanisms in Parkinsons disease

Ghrelin MKDA: elevated reward responses with high ghrelin To estimate the hypothesized reward-enhancing effect of ghrelin, we conducted a meta-analysis of positive associations with ghrelin

Researchers say these findings indicate physicians prescribing Wegovy should monitor for signs of blood clots and ensure proper hydration to reduce risks, and caution should be used when prescribing Wegovy to patients with a predisposition to blood clots

The current fiscal strategy marks a turning point: from expansion to cost containment